Shanghai Biopharmaleader co.,ltd

Date: 19th July 2016
XL-518 CAS:934660-93-2
If you are going to consult the information about 934660-93-2 from one of the leading 934660-93-2 manufacturers and suppliers in China, Biopharmaleader Co.,Ltd is always at your service.Product Information?CAS NO.934660-93-2?Product NameCobimetinibSynonymsXL-518;GDC-0973FormulaC21H21F3IN3O2Molecular Weight531.31Spec / Purity98%minSupply CapacityDetailsCobimetinib (GDC-0973, XL-518) is a MEK inhibitor being . It is being studied in combination with BRAF inhibitors to treat several cancers. Early data showed that administration of Cobimetinib in combination with the BRAF inhibitor vemurafenib increased progression-free survival in melanoma patients with a BRAF V600 mutation by 3.7 months compared to vemurafenib alone. Phase 3 clinical trials are ongoing and expected to complete by 2017. After good results in 2014 the combination has been submitted to EC and FDA for marketing approval.?
Latest News
Contact Information



Building 11, NO. 3802 ShenGang Rd, Xinfei Corporation Home, SongJiang District, Shanghai,201611, China.
Shanghai, 201611


Contact Form